APA (7th ed.) Citation

C, B., Q, S., XX, L., M, Z., Z, R., Z, D., . . . B, L. (2026). Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration. American journal of cardiovascular drugs : drugs, devices, and other interventions, 26(4), 435. https://doi.org/10.1007/s40256-026-00794-9

Chicago Style (17th ed.) Citation

C, Bian, Shen Q, Liu XX, Zhou M, Ren Z, Dong Z, Jin X, Song B, and Li B. "Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 26, no. 4 (2026): 435. https://doi.org/10.1007/s40256-026-00794-9.

MLA (9th ed.) Citation

C, Bian, et al. "Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, vol. 26, no. 4, 2026, p. 435, https://doi.org/10.1007/s40256-026-00794-9.